• Je něco špatně v tomto záznamu ?

Neuropsychological Performance after Brain Arteriovenous Malformations Treatment

O. Bradac, A. Pulkrabkova, P. de Lacy, V. Benes,

. 2017 ; 78 (4) : 321-328. [pub] 20161111

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016921

Background The treatment of brain arteriovenous malformations (AVMs) has been studied extensively. With the use of the Spetzler-Martin (S-M) grading system, patients can be informed appropriately about their possible surgical risks. This does not hold true for their neuropsychological sequelae, which have not been studied widely. We evaluated the neuropsychological outcome of our patients treated for brain AVMs. Methods Of 113 patients treated for a brain AVM between 2001 and 2009, 66 patients were enrolled in the study. All patients underwent treatment at our institution and neuropsychological testing 2 years later using a test battery constructed specifically for this study. A control group consisted of 10 subjects without any neurologic disease. Results When the whole cohort was analyzed, no significant differences were found between the groups distinguished by hemorrhage, gender, or hemispheric dominance. Patients with S-M IV and V scores fared significantly worse than patients with S-M I to III. Patients who presented with epilepsy scored lower than patients presenting with other symptomatology, but the difference had only borderline significance. When we analyzed patients according to the presence or absence of obliteration after treatment and compared these with the control group, we found no significant differences. When the patients with an obliterated AVM after treatment were subdivided according to treatment modality, there were no significant differences in their S-M groups compared with the control group. Similarly, those patients with nonobliterated AVMs analyzed according to their S-M grade showed a borderline significant difference, with S-M IV and V having a worse neuropsychological outcome compared with the other groups. Conclusions Patients harboring nonobliterated high-grade AVMs (S-M IV and V) scored worse than patients with nonobliterated AVM S-M grades I to III. This could be explained by the steal phenomenon. No differences in neuropsychological testing were found when comparing results according to nidus location. This study lends support to an active treatment policy for cerebral AVMs. Those patients in whom complete obliteration was achieved with treatment scored similarly to the background population, implying active AVM treatment does not cause deterioration in neuropsychological performance. This, together with a > 90% AVM obliteration rate, favors microsurgery as the treatment modality of choice whenever the AVM can be safely resected.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016921
003      
CZ-PrNML
005      
20180523132115.0
007      
ta
008      
180515s2017 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1055/s-0036-1592420 $2 doi
035    __
$a (PubMed)27835916
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Bradac, Ondrej $u Department of Neurosurgery and Neurooncology, Military University Hospital and Charles University, First Medical Faculty, Prague, Czech Republic.
245    10
$a Neuropsychological Performance after Brain Arteriovenous Malformations Treatment / $c O. Bradac, A. Pulkrabkova, P. de Lacy, V. Benes,
520    9_
$a Background The treatment of brain arteriovenous malformations (AVMs) has been studied extensively. With the use of the Spetzler-Martin (S-M) grading system, patients can be informed appropriately about their possible surgical risks. This does not hold true for their neuropsychological sequelae, which have not been studied widely. We evaluated the neuropsychological outcome of our patients treated for brain AVMs. Methods Of 113 patients treated for a brain AVM between 2001 and 2009, 66 patients were enrolled in the study. All patients underwent treatment at our institution and neuropsychological testing 2 years later using a test battery constructed specifically for this study. A control group consisted of 10 subjects without any neurologic disease. Results When the whole cohort was analyzed, no significant differences were found between the groups distinguished by hemorrhage, gender, or hemispheric dominance. Patients with S-M IV and V scores fared significantly worse than patients with S-M I to III. Patients who presented with epilepsy scored lower than patients presenting with other symptomatology, but the difference had only borderline significance. When we analyzed patients according to the presence or absence of obliteration after treatment and compared these with the control group, we found no significant differences. When the patients with an obliterated AVM after treatment were subdivided according to treatment modality, there were no significant differences in their S-M groups compared with the control group. Similarly, those patients with nonobliterated AVMs analyzed according to their S-M grade showed a borderline significant difference, with S-M IV and V having a worse neuropsychological outcome compared with the other groups. Conclusions Patients harboring nonobliterated high-grade AVMs (S-M IV and V) scored worse than patients with nonobliterated AVM S-M grades I to III. This could be explained by the steal phenomenon. No differences in neuropsychological testing were found when comparing results according to nidus location. This study lends support to an active treatment policy for cerebral AVMs. Those patients in whom complete obliteration was achieved with treatment scored similarly to the background population, implying active AVM treatment does not cause deterioration in neuropsychological performance. This, together with a > 90% AVM obliteration rate, favors microsurgery as the treatment modality of choice whenever the AVM can be safely resected.
650    _2
$a dospělí $7 D000328
650    _2
$a kognitivní poruchy $x diagnóza $x etiologie $7 D003072
650    _2
$a terapeutická embolizace $x škodlivé účinky $7 D004621
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a intrakraniální arteriovenózní malformace $x komplikace $x chirurgie $7 D002538
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikrochirurgie $x škodlivé účinky $7 D008866
650    _2
$a lidé středního věku $7 D008875
650    12
$a neuropsychologické testy $7 D009483
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pulkrabkova, Alice $u Department of Psychology, Military University Hospital, Prague, Czech Republic.
700    1_
$a de Lacy, Patricia $u Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield, United Kingdom.
700    1_
$a Benes, Vladimir $u Department of Neurosurgery and Neurooncology, Military University Hospital and Charles University, First Medical Faculty, Prague, Czech Republic.
773    0_
$w MED00179151 $t Journal of neurological surgery. Part A, Central European neurosurgery $x 2193-6323 $g Roč. 78, č. 4 (2017), s. 321-328
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27835916 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180523132259 $b ABA008
999    __
$a ok $b bmc $g 1300545 $s 1013761
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 78 $c 4 $d 321-328 $e 20161111 $i 2193-6323 $m Journal of neurological surgery. Part A, Central European neurosurgery $n J Neurol Surg A Cent Eur Neurosurg $x MED00179151
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...